الأخ الفاضل المؤشر والاخوة

الموضوع في 'السوق الأمريكي للأوراق الماليه' بواسطة NWAAF_10, بتاريخ ‏24 سبتمبر 2003.

  1. NWAAF_10

    NWAAF_10 عضو جديد

    التسجيل:
    ‏1 أكتوبر 2001
    المشاركات:
    167
    عدد الإعجابات:
    0
    السلام عليكم

    اخي ابو على لو تعطيني مريئتكم عن سهم BIOM


    والاخوه ما قصروا عطار وممدوح الله يعطيهم العافيه قول وفعل الله يجزاكم كل خيررررررررررررررر

    لكن بعد الخبر هذا طاح ونزل ..
    واخر اخباره هوBiomira Announces U.S. $16.3 Million Financing
    Market Wire, Monday, September 22, 2003 at 09:06



    Biomira Inc. (NASDAQ: BIOM) (TSX: BRA)
    announced today that it has arranged a financing, totaling U.S.$16,290,000,
    with Rodman & Renshaw, Inc. of New York acting as exclusive placement
    agent. In respect of this financing, Biomira intends to file shortly in
    Canada a prospectus supplement to its April 30, 2002 Base Shelf Prospectus
    and in the United States a prospectus supplement to its April 30, 2002 F-10
    Registration Statement. The financing is expected to close at the earliest
    opportunity.



    The Company will be offering up to 9 million common shares at an issue
    price of U.S.$1.81, which represents a premium of 7.6 per cent over the
    U.S.$1.682 average of the closing bid price of Biomira common shares as
    quoted on the Nasdaq National Market for the five trading days up to and
    including September 18, 2003.



    The issue will include up to 2,070,000 warrants. Each purchaser
    participating in the offering will receive 0.23 warrants for every common
    share purchased in the offering. Each warrant will entitle the holder
    thereof to purchase one common share at an exercise price of U.S. $2.30.
    The warrants will have a two year term, expiring September 18, 2005, and a
    "no exercise period" of six months.



    "Our financial goal is to have sufficient funds to aggressively move our
    two lead product candidates to the next level," said Edward Taylor, Vice
    President Finance and Chief Financial Officer. "With the completion of
    this additional financing, we feel we are well on the way to accomplishing
    that goal."



    Biomira is a biotechnology company specializing in the development of
    innovative therapeutic approaches to cancer management. Biomira's
    commitment to the treatment of cancer currently focuses on the development
    of synthetic vaccines and novel strategies for cancer immunotherapy. We
    are The Cancer Vaccine People™.



    This release may contain forward-looking statements. Various factors could
    cause actual results to differ materially from those projected in
    forward-looking statements, including those predicting the timing and
    results of clinical trials, availability or adequacy of financing, the
    sales and marketing of commercial products or the efficacy of products.
    Although the Company believes that the forward-looking statements contained
    herein are reasonable, it can give no assurance that the Company's
    expectations are correct. All forward-looking statements are expressly
    qualified in their entirety by this cautionary statement.



    ودي استثمر فيه 500 الف ريال ومتردد لكن سعره 1.85 دولار

    اتمنى القى رد منكم اخي سيف العجمي

    وبالتوفيق للجميع وتحياتي